BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260130T120000
DTEND;TZID=Europe/Stockholm:20260130T130000
DTSTAMP:20260406T174918
CREATED:20260114T083003Z
LAST-MODIFIED:20260114T084059Z
UID:10001717-1769774400-1769778000@www.scilifelab.se
SUMMARY:Calls for new project support in Chemical Biology and Drug Discovery
DESCRIPTION:The Chemical Biology Unit (CBCS) and the Drug Discovery and Development (DDD) platform at SciLifeLab have calls out for projects. \n\n\n\nCBCS is seeking projects in Chemical Biology that include assay development for small-molecule screening and profiling\, as well as enabling chemistry.  \n\n\n\nFor more information\, please visit www.cbcs.se. \n\n\n\nThe DDD platform is looking for new project proposals for drug discovery. All therapeutic modalities that can be developed in collaboration with the DDD platform at SciLifeLab are of interest\, including small molecules\, antibodies\, oligonucleotides and new modalities. \n\n\n\nSome users and projects are at the intersection between chemical biology and drug discovery. This webinar aims to guide users to the call that best suits the needs of their project \n\n\n\nRegister here!\n\n\n\nOrganizer: the Chemical Biology Consortium Sweden and the Drug Discovery & Development platform
URL:https://www.scilifelab.se/event/calls-for-new-project-support-in-chemical-biology-and-drug-discovery-4/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250905T120000
DTEND;TZID=Europe/Stockholm:20250905T130000
DTSTAMP:20260406T174918
CREATED:20250826T113136Z
LAST-MODIFIED:20250828T081017Z
UID:10001589-1757073600-1757077200@www.scilifelab.se
SUMMARY:Exploring biology with small molecules and opportunities for early drug discovery
DESCRIPTION:Open call for project support within our service areas – from assay development and small molecule screening through drug profiling to medicinal/synthetic/organic and computational chemistry support. \n\n\n\nRegister to receive the zoom link\n\n\n\nCall for new project proposals for drug discovery. DDD supports a project portfolio consisting of about 20 programs and we foresee a need to replenish our portfolio with 3-5 new programs in 2025. We are interested in programs with defined targets for diseases with medical needs using any therapeutic modality\, e.g. antisense oligonucleotides\, small molecules\, antibodies and/or proximity-inducers. \n\n\n\nflyer_webinar CBCS DDD 2025_2Download
URL:https://www.scilifelab.se/event/exploring-biology-with-small-molecules-and-opportunities-for-early-drug-discovery/
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2025/08/AdobeStock_1345238475-scaled.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240815T110000
DTEND;TZID=Europe/Stockholm:20240815T114500
DTSTAMP:20260406T174918
CREATED:20240624T140804Z
LAST-MODIFIED:20240624T141010Z
UID:10001286-1723719600-1723722300@www.scilifelab.se
SUMMARY:Calls for new project support from  chemical biology and genome engineering platform and the drug discovery & development platform
DESCRIPTION:The Chemical Biology and Genome Engineering platform and the Drug discovery and development (DDD) platform at SciLifeLab have calls out for projects support. \n\n\n\nThe Chemical Biology unit looks projects proposals including including assay development\, small molecule screening\, drug profiling\, and medicinal and computational chemistry.  For more information\, please visit www.cbcs.se. \n\n\n\nThe Chemical Biology and Genome Engineering platform are inviting project proposals aiming to explore compounds/drugs mechanism of action that harness the combined strengths of at least two platform units. If approved\, these projects will gain cost-effective access to CBGE’s cutting-edge technologies \n\n\n\nBoth the above welcome proposals in all areas of biology not only in human health. \n\n\n\nThe DDD platform has a call looking for new project proposals for drug discovery. All therapeutic modalities that can be developed in collaboration with the DDD platform at SciLifeLab are of interest\, including small molecules\, antibodies\, oligonucleotides and new modalities. \n\n\n\nSome users and projects are at the intersection between chemical biology and drug discoveryhttps://ki-se.zoom.us/j/61032835991 \n\n\n\nProgram: \n\n\n\n1. Presentation of CBGE offerings \n\n\n\n2. Presentation of the DDDp offerings \n\n\n\n3. Q/A
URL:https://www.scilifelab.se/event/calls-for-new-project-support-from-chemical-biology-and-genome-engineering-platform-and-the-drug-discovery-development-platform/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20230927T100000
DTEND;TZID=Europe/Stockholm:20230927T110000
DTSTAMP:20260406T174918
CREATED:20230810T123528Z
LAST-MODIFIED:20230829T092737Z
UID:10000944-1695808800-1695812400@www.scilifelab.se
SUMMARY:Blending Chemistry and Biology to Enable Systems Pharmacology
DESCRIPTION:Patrick Aloy\, Prof.\, Institute for Research in Biomedicine (IRB Barcelona) \n\n\n\n \n\n\n\nOrganizers \n\n\n\nCBCS-KI and PhenoTarget Research Community Program \n\n\n\nJoin the seminar on Zoomhttps://ki-se.zoom.us/j/64473979770 \n\n\n\nAbstract \n\n\n\nBig Data analytical techniques and AI have the potential to transform drug discovery\, as they are reshaping other areas of science and technology\, but we need to blend biology and chemistry in a format that is amenable for modern machine learning. In this talk\, I will present the Chemical Checker (CC)\, a resource that provides processed\, harmonized and integrated bioactivity data on small molecules. The CC divides data into five levels of increasing complexity\, ranging from the chemical properties of compounds to their clinical outcomes. In between\, it considers targets\, off-targets\, perturbed biological networks and several cell-based assays such as gene expression\, growth inhibition and morphological profiles. I will also present the Bioteque\, a resource of unprecedented size and scope that contains pre-calculated biomedical embeddings around 11 biological entities (e.g. genes\, cells\, tissues\, disease\, etc)\, derived from a gigantic knowledge graph\, so that each entity can be described considering different contexts (e.g. interactions\, expression\, etc). With small molecule and biological bioactivity descriptors in hand\, we now face a new scenario for chemical and biological entities where they both are translated into a common numerical format. In this computational framework\, complex connections between entities can be unveiled by means of simple arithmetic operations. Indeed\, we demonstrate and experimentally validate that these descriptors can be used to reverse and mimic biological signatures of disease models and genetic perturbations in vitro and in vivo\, options that are otherwise impossible using chemical information alone.ReferencesDuran-Frigola et al. Extending the small molecule similarity principle to all levels of biology with the Chemical Checker. 2020. Nat Biotechnol. 38: 1087-1096. \n\n\n\nBertoni et al. Bioactivity descriptors for uncharacterized chemical compounds. 2021. Nat Commun. 12: 3932. \n\n\n\nPauls et al. Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F\, AppNL-F\, and 3xTg-AD mouse models. 2021. Genome Med. 13:168. \n\n\n\nFernández-Torras et al. Connecting chemistry and biology through molecular descriptors. 2022. Curr Opin Chem Biol\, 66: 102090. \n\n\n\nFernández-Torras et al. Integrating and formatting biomedical data in the Bioteque\, a comprehensive repository of pre-calculated knowledge graph embeddings. 2022. Nat Commun. 13: 5304.
URL:https://www.scilifelab.se/event/blending-chemistry-and-biology-to-enable-systems-pharmacology/
LOCATION:Gamma 2 Lunchroom\, SciLifeLab\, Tomtebodavägen 23\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20230509T080000
DTEND;TZID=Europe/Stockholm:20230511T170000
DTSTAMP:20260406T174918
CREATED:20230413T131100Z
LAST-MODIFIED:20230413T131140Z
UID:10000857-1683619200-1683824400@www.scilifelab.se
SUMMARY:European Chemical Biology Symposium
DESCRIPTION:The free event will combine ELRIG’s inaugural meeting on Therapeutic OLIGOs with the 8th European Chemical Biology Symposium (ECBS) and will be held in Gothenburg\, Sweden from May 9–11. Over the three days\, academia\, industry\, and the vendor community will discuss recent advancements in two ultra-exciting areas of drug discovery and biological research: therapeutic oligonucleotides and chemical biology. \n\n\n\nSpeakers range from breakthrough therapeutic oligo pioneer Frank Bennet\, to the vastly experienced Marie Vikstrom Lindholm of Silence Therapeutics. \n\n\n\nKeynote speakers\n\n\n\nFrank Bennett\, Katherine Donovan\, Steven Dowdy\, Marie Wikstrom Lindholm and Shantanu Singh. \n\n\n\nPresenters\n\n\n\nPetr Bartunek\, Tom Brown\, Peter Crowley\, Samir EL Andaloussi\, Simon Elsässer\, Alice Ghidini\, Aurelie Goyenvalle\, Peter Hagedorn\, Emma Kay\, Stefan Kubicek\, Michael Kurczy\, Pär Matsson\, Cristina Mayor-Ruiz\, Rui Moreira\, Sílvia Osuna\, Andrea Rentmeister\, Chiara Saponaro\, Sabine Sewing. \n\n\n\nRead more
URL:https://www.scilifelab.se/event/european-chemical-biology-symposium/
LOCATION:AstraZeneca\, PGN Entrance\, Pepparedsleden 5\, Mölndal\, 431 53
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20221214T153000
DTEND;TZID=Europe/Stockholm:20221214T170000
DTSTAMP:20260406T174918
CREATED:20221212T153057Z
LAST-MODIFIED:20221212T153059Z
UID:10000748-1671031800-1671037200@www.scilifelab.se
SUMMARY:Chemical Biology Seminar Series
DESCRIPTION:“TARGETING RIBOSOME BIOGENESIS IN CANCER” \n\n\n\nDimitris KanellisDept. of Medical Biochemistry and Biophysics\, Karolinska Institutet“SYNTHETIC SWITCHES FOR DNA REPAIR – CONTROLLING ENZYMATIC FUNCTIONS AT WILL”Maurice MichelDept. of Oncology-Pathology\, Karolinska Institutet \n\n\n\nDate: Wednesday December 14 \n\n\n\nTime: 3.30 pm \n\n\n\nLocation: Air & Fire\, SciLifeLab \n\n\n\nThe seminars are also available on Zoom. \n\n\n\n\nhttps://ki-se.zoom.us/j/66622023014
URL:https://www.scilifelab.se/event/chemical-biology-seminar-series/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20221124T150000
DTEND;TZID=Europe/Stockholm:20221124T170000
DTSTAMP:20260406T174918
CREATED:20221121T152910Z
LAST-MODIFIED:20221122T094801Z
UID:10000737-1669302000-1669309200@www.scilifelab.se
SUMMARY:Chemical Biology Seminar
DESCRIPTION:“DATA-DRIVEN HALLMARKS OF ACUTE MYELOID LEUKEMIA: \n\n\n\nBIOLOGICAL\, PROGNOSTIC AND THERAPEUTIC IMPLICATIONS” \n\n\n\nTom Erkers  \n\n\n\nAssistant professor\, Dept. of Oncology-Pathology\, Karolinska Institutet \n\n\n\n“SYNTHETIC SWITCHES FOR DNA REPAIR –  \n\n\n\nCONTROLLING ENZYMATIC FUNCTIONS AT WILL” \n\n\n\nMaurice Michel \n\n\n\nAssistant professor\, Dept. of Oncology-Pathology\, Karolinska Institutet \n\n\n\n \n\n\n\nNov. 24 at 3.30 pm \n\n\n\nGamma 2 Lunch Room\, SciLifeLab Stockholm \n\n\n\nAnd on Zoom \n\n\n\n\nhttps://ki-se.zoom.us/j/64941340588
URL:https://www.scilifelab.se/event/chemical-biology-seminar/
LOCATION:Gamma 2 Lunchroom\, SciLifeLab\, Tomtebodavägen 23\, Solna\, Sweden
CATEGORIES:Community
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20221027T153000
DTEND;TZID=Europe/Stockholm:20221027T170000
DTSTAMP:20260406T174918
CREATED:20221003T150502Z
LAST-MODIFIED:20221003T150536Z
UID:10000704-1666884600-1666890000@www.scilifelab.se
SUMMARY:Developing therapies for the inherited bone marrow failure syndrome diamond-blackfan anemia
DESCRIPTION:Johan Flygare \n\n\n\nDocent\, MD and PhD\, Department of Laboratory Medicine\, Lund University \n\n\n\n \n\n\n\nHost: Mikael Lindström\, Docent and PhD \n\n\n\nOctober 27 at 3.30 pm \n\n\n\nSeminar room: Air & Fire \n\n\n\nOrganizers: CBCS-KI and PhenoTarget Research Community Program
URL:https://www.scilifelab.se/event/developing-therapies-for-the-inherited-bone-marrow-failure-syndrome-diamond-blackfan-anemia/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220815T113000
DTEND;TZID=Europe/Stockholm:20220815T121500
DTSTAMP:20260406T174918
CREATED:20220615T132143Z
LAST-MODIFIED:20220622T114102Z
UID:10000625-1660563000-1660565700@www.scilifelab.se
SUMMARY:Calls for new project support in chemical biology and drug discovery
DESCRIPTION:The chemical biology unit (CBCS) and the Drug discovery and development (DDD) platform at SciLifeLab have calls out for projects. \n\n\n\nCBCS is looking for projects in Chemical Biology which includes assay development for small molecule screening and profiling\, as well as enabling chemistry. For more information\, please visit www.cbcs.se. \n\n\n\nThe DDD platform has a call looking for new project proposals for drug discovery. All therapeutic modalities that can be developed in collaboration with the DDD platform at SciLifeLab are of interest\, including small molecules\, antibodies\, oligonucleotides and new modalities. \n\n\n\nSome users and projects are at the intersection between chemical biology and drug discovery.This webinar aims to guide users to the call that best suits the needs of their project. \n\n\n\nRegistration
URL:https://www.scilifelab.se/event/calls-for-new-project-support-in-chemical-biology-and-drug-discovery/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
END:VCALENDAR